Interpreting Subgroup Analyses: Is a School-Based Asthma Treatment Program's Effect Modified by Secondhand Smoke Exposure?

Archives of Pediatrics and Adolescent Medicine

Volumn 158, Issue 5, 2004, Pages 469-471

  Bundy, David G ^a,b   Berkoff, Molly Curtin ^a   Ito, Kristin E ^a   Rosenthal, Marjorie S ^a   Weinberger, Morris ^a  

^a CB7105 ^*

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; STEROID;

ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; ENVIRONMENTAL EXPOSURE; GROUP DYNAMICS; GROUP PSYCHOLOGY; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PASSIVE SMOKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SAMPLE SIZE; SCHOOL HEALTH SERVICE; SMOKE; STANDARD; SUBGROUP ANALYSIS; SYMPTOMATOLOGY;

ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; HUMANS; RESEARCH DESIGN; SCHOOL HEALTH SERVICES; TOBACCO SMOKE POLLUTION; TREATMENT OUTCOME;

EID: 2442436097     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.158.5.469     Document Type: Review

References (12)

1. Halterman JS, Szilagyi PG, Yoos HL, et al. Benefits of a school-based asthma treatment program in the absence of secondhand smoke exposure. Arch Pediatr Adolesc Med. 2004;158:460-467.
2. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature, II: how to use an article about therapy or prevention, are the results of the study valid? Evidence-Based Medicine Working Group. JAMA. 1993;270:2598-2601.
3. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature, II: how to use an article about therapy or prevention, B. what were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA. 1994;271:59-63.
4. Bukstein DA, Luskin AT, Bernstein A. "Real-world" effectiveness of daily controller medicine in children with mild persistent asthma. Ann Allergy Asthma Immunol. 2003;90:543-549.
5. McQuaid EL, Kopel SJ, Klein RB, Fritz GK. Medication adherence in pediatric asthma: reasoning, responsibility, and behavior. J Pediatr Psychol. 2003;28:323-333.
6. Dubus JC, Anhoj J. A review of once-daily delivery of anti-asthmatic drugs in children. Pediatr Allergy Immunol. 2003;14:4-9.
7. National Institutes of Health, National Heart, Lung, and Blood Institute. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute; 1997.
8. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 1992;116:78-84.
9. Guyatt G, Rennie D, eds. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. Chicago, III: AMA Press; 2002.
10. Soussan D, Liard R, Zureik M, Touron D, Rogeaux Y, Neukirch F. Treatment compliance, passive smoking, and asthma control: a three year cohort study. Arch Dis Child. 2003;88:229-233.
11. Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 2002;57:226-230.
12. Cox G, Whitehead L, Dolovich M, Jordana M, Gauldie J, Newhouse MT. A randomized controlled trial on the effect of inhaled corticosteroids on airways inflammation in adult cigarette smokers. Chest. 1999;115:1271-1277.